40 /100
MEDIUM RISK
Score updated May 28, 2026

IMRX — Immuneering Corporation Dilution Risk Tracker

Track IMRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IMRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
📉 Score Deterioration 40%
• Score rose 19 points recently (worsening)
🔔 Track IMRX — Get forecast alerts →

💹 Market Data

Market Cap$345.16M
Shares Outstanding64.70M
Float49.44M
Cash$156.69M
Debt$3.73M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 25.6% shares (2025Q4 vs prior)
87 institutional holders · 32.99M shares
#1 FMR LLC 9.69M shares
#2 Sanofi 2.71M shares
#3 Empery Asset Management, LP 2.67M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest9.50M
Days to Cover11.6
% of Float19.2%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
xbrl XBRL WARRANT Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track IMRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IMRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for IMRX
📊 IMRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IMRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.